Hubei Enoray Biopharmaceutical Co., Ltd.

NEWS

The Yinuorui Party Branch held a themed Party Day activity titled “Studying and Implementing the Spirit of the Plenary Session, Uniting Hearts and Gathering Strength to Plan and Launch the New Journey.”

2026-01-20

The Yinuorui Party Branch held a special briefing on the spirit of the Fourth Plenary Session of the 20th Central Committee.

2025-12-18

Yinuorui Company Conducts Mechanical Injury Accident and Fire Drill Exercises.

2025-12-01

Yinuorui’s 2025 Safety Production Month: Fire Emergency Drill to Strengthen Safety Awareness

2025-06-27

The 2024 cohort of YinoRui management trainees’ rotation summary and report meeting was successfully held.

2024-10-23

The Yinuorui Party Branch successfully held the Party-building themed activity “Inheriting the Red Gene and Practicing Our Original Aspiration and Mission.”

2024-08-29

Wu Wenyuan, Chairman of Hongri Pharmaceutical Group, and his delegation visited Yinuorui for inspection and guidance.

2024-08-12

Yinuorui Company held a Party member conference and carried out the May-themed Party Day activity.

2024-05-21

Carry out safety inspections for resuming work and production, and fortify the safety defense line.

2024-02-23

Focusing on Overseas Markets and Deepening Cost Reduction and Efficiency Enhancement—Yinuorui’s Annual Awards Ceremony Held Successfully

2024-02-07

The Yinuorui Party Branch held a themed Party Day activity titled “Studying and Implementing the Spirit of the Plenary Session, Uniting Hearts and Gathering Strength to Plan and Launch the New Journey.”

On the morning of January 16, 2026, the Party branch of Hubei Enoray Biopharmaceutical Co., Ltd. organized a themed Party Day activity titled "Studying and Implementing the Spirit of the Plenary Session, Uniting Hearts and Gathering Strength to Plan and Launch the New Journey" in the Party member activity room.

The Yinuorui Party Branch held a special briefing on the spirit of the Fourth Plenary Session of the 20th Central Committee.

2025-12-18

Yinuorui Company Conducts Mechanical Injury Accident and Fire Drill Exercises.

2025-12-01

Yinuorui’s 2025 Safety Production Month: Fire Emergency Drill to Strengthen Safety Awareness

2025-06-27

Low-molecular-weight heparin calcium API

Name: LMWH Calcium

Grade: Injection-grade

Product Capacity: 1500 kg/year

Specification: ChP

Production Site: GMP workshop

Enoxaparin Sodium Active Pharmaceutical Ingredient

Name: Sodium Enoxaparin

Grade: Injection-grade

Product Capacity: 3000 kg/year

Specification: EP/BP/USP

Production Site: GMP workshop

Sodium Dalteparin API

Name: Dalteparin Sodium

Grade: Injection-grade

Product Capacity: 500 kg/year

Specification: EP/BP

Production Site: GMP workshop

Crude sodium heparin

Name: Crude Sodium Heparin

Grade: Crude product

Product Capacity: 200 billion units per year

Specification: In-House

Production Site: GMP workshop

Heparin Sodium Active Pharmaceutical Ingredient

Name: Heparin Sodium

Grade: Injection-grade / Topical-grade

Product Capacity: 150 billion units per year

Specification: EP/BP/USP/ChP

Production Site: GMP workshop

Calcium nadroparin raw material

Name: Nadroparin Calcium

Grade: Injection-grade

Product Capacity: 2500 kg/year

Specification: EP/BP/ChP

Production Site: GMP workshop

Hubei Enoray Biopharmaceutical Co., Ltd. is a high-tech biopharmaceutical enterprise specializing in the research and development, production, sales, and export of heparin, fractionated low-molecular-weight heparin APIs, and novel antithrombotic drugs. Founded in November 2010 [View Details]